HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Candriam Luxembourg S.C.A.

Candriam Luxembourg S.C.A. lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 9.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 110,639 shares of the company’s stock after selling 11,071 shares during the quarter. Candriam Luxembourg S.C.A.’s holdings in HCA Healthcare were worth $27,727,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HCA. Ellevest Inc. lifted its stake in shares of HCA Healthcare by 33.6% during the first quarter. Ellevest Inc. now owns 187 shares of the company’s stock valued at $47,000 after buying an additional 47 shares during the period. Veriti Management LLC boosted its holdings in shares of HCA Healthcare by 4.0% during the first quarter. Veriti Management LLC now owns 1,297 shares of the company’s stock worth $325,000 after purchasing an additional 50 shares during the last quarter. Oliver Luxxe Assets LLC increased its stake in HCA Healthcare by 0.4% in the fourth quarter. Oliver Luxxe Assets LLC now owns 13,470 shares of the company’s stock valued at $3,461,000 after purchasing an additional 51 shares during the last quarter. Highland Private Wealth Management boosted its stake in HCA Healthcare by 6.4% in the 1st quarter. Highland Private Wealth Management now owns 876 shares of the company’s stock worth $220,000 after buying an additional 53 shares during the last quarter. Finally, Balasa Dinverno & Foltz LLC increased its stake in shares of HCA Healthcare by 4.5% during the 1st quarter. Balasa Dinverno & Foltz LLC now owns 1,244 shares of the company’s stock valued at $312,000 after acquiring an additional 54 shares during the last quarter. 65.75% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at HCA Healthcare

In related news, major shareholder Patricia F. Elcan acquired 325 shares of the business’s stock in a transaction that occurred on Monday, July 25th. The shares were acquired at an average cost of $198.66 per share, for a total transaction of $64,564.50. Following the completion of the purchase, the insider now directly owns 89,337 shares in the company, valued at $17,747,688.42. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 1.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on HCA shares. Loop Capital assumed coverage on shares of HCA Healthcare in a research report on Thursday, June 16th. They set a “buy” rating and a $240.00 price target for the company. The Goldman Sachs Group lowered their price target on HCA Healthcare from $270.00 to $233.00 and set a “buy” rating for the company in a research report on Tuesday, July 12th. Stephens lifted their price objective on HCA Healthcare to $230.00 in a research note on Monday, July 25th. Sanford C. Bernstein upgraded shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and cut their price target for the company from $273.00 to $271.00 in a report on Thursday, May 26th. Finally, Truist Financial increased their price target on HCA Healthcare from $208.00 to $240.00 and gave the company a “buy” rating in a report on Monday, July 25th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $237.71.

HCA Healthcare Trading Up 1.9 %

NYSE HCA opened at $216.21 on Friday. The firm has a market capitalization of $62.06 billion, a PE ratio of 10.40, a price-to-earnings-growth ratio of 1.48 and a beta of 1.72. The company has a 50-day simple moving average of $198.32 and a 200-day simple moving average of $218.04. HCA Healthcare, Inc. has a one year low of $164.47 and a one year high of $279.02. The company has a debt-to-equity ratio of 87.46, a quick ratio of 1.32 and a current ratio of 1.55.

HCA Healthcare (NYSE:HCAGet Rating) last issued its quarterly earnings data on Friday, July 22nd. The company reported $4.21 EPS for the quarter, topping analysts’ consensus estimates of $3.67 by $0.54. HCA Healthcare had a return on equity of 833.68% and a net margin of 10.83%. The firm had revenue of $14.82 billion during the quarter, compared to the consensus estimate of $14.73 billion. During the same period in the prior year, the business earned $4.37 EPS. The firm’s revenue was up 2.7% on a year-over-year basis. On average, equities analysts forecast that HCA Healthcare, Inc. will post 17.1 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 30th. Shareholders of record on Friday, September 16th will be paid a $0.56 dividend. The ex-dividend date is Thursday, September 15th. This represents a $2.24 annualized dividend and a dividend yield of 1.04%. HCA Healthcare’s payout ratio is currently 10.77%.

HCA Healthcare Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.